Medicare Enrolled

Dr. Rukmini Rednam, M.D.

Vascular Surgery · Houston, TX
Speaking/Promotional
9230 KATY FWY STE 600, Houston, TX 77055
7137910700
In practice since 2008 (17 years)
NPI: 1477706463 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rednam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rednam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rednam

Dr. Rukmini Rednam is a vascular surgery specialist in Houston, TX, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Rednam received a total of $94,542 from 23 pharmaceutical and/or device companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in vascular surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rednam is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $94,542 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$94,542
Total received (2018-2024)
Avg $13,506/year across 7 years
Top 3% in TX for vascular surgery
23
Companies
221
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,776 (63.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,464 (32.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,945 (4.2%)
Other
Charitable contributions, space rental, and other categories
$358 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33,392
2023
$27,210
2022
$31,504
2021
$1,240
2020
$628
2019
$423
2018
$145

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$59,326
Allergan, Inc.
$30,901
Mentor Worldwide LLC
$1,287
Davol Inc.
$554
Galderma Laboratories, L.P.
$462
Integra LifeSciences Corporation
$428
Musculoskeletal Transplant Foundation Inc.
$290
Tepha Inc
$250
Inspire Medical Systems, Inc.
$240
MOTIVA USA, LLC
$222
RTI SURGICAL, INC
$102
Sientra, Inc.
$100
REVANCE THERAPEUTICS, INC.
$74
KCI USA, Inc.
$64
Allergan Inc.
$50
Pacira Pharmaceuticals Incorporated
$39
GENZYME CORPORATION
$39
Smith+Nephew, Inc.
$30
Optinose US, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$19
Olympus America Inc.
$17
Heron Therapeutics, Inc.
$13
CooperSurgical, Inc.
$11
Top 3 companies account for 96.8% of total payments
Associated products mentioned in payments ›
AGENTO · ALLODERM · ARTOURA Breast Tissue Expander · BOTOX · CORTIVA ALLOGRAFT DERMIS · DAXXIFY · DUPIXENT · DuraSorb Monofilament Mesh · Exparel · GalaFLEX · INSPIRE · MENTOR CPX 2 Breast Tissue Expander · MENTOR MemoryGel Resterilizable Gel Sizer · MemoryGel Breast Implants · Motiva Implant Matrix · NATRELLE · NATRELLE SALINE-FILLED BREAST IMPLANTS · OMNIGRAFT · PICO · PICO 7 · PREVENA · Phasix Mesh · REVOLVE · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS · SURGIMEND · Uterine Manipulators & Injectors · Xhance · ZYNRELEF
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in vascular surgery and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for vascular surgery in TX.

Looking for a vascular surgery specialist in Houston?
Compare vascular surgerists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse vascular surgerists nearby

Geographic Context

Vascular surgerists within 10 mi
77
Per 100K population
1.6
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rednam is a vascular surgery specialist, with speaking/promotional industry engagement in the top 3% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Rednam receive payments from pharmaceutical companies?
Yes. Dr. Rednam received a total of $94,542 from 23 companies across 221 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Rednam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →